Aclaris Therapeutics Inc (0H8T.L)

Healthcare | Medical Pharmaceuticals
Income Statement (Quarterly) 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue 1,777,000 1,455,000 9,211,000 4,346,000
Cost of Revenue 515,000 506,000 9,301,000 2,408,000
Gross Profit 1,262,000 949,000 -90,000 1,938,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 5,386,000 6,139,000 4,954,000 5,653,000
Operating Expenses 19,670,000 19,033,000 99,585,000 12,409,000
Operating Income -18,408,000 -18,084,000 -99,675,000 -10,471,000
Interest Expense 0 0 0 0
Income Before Tax -15,429,000 -15,085,000 -96,552,000 -7,586,000
Income Tax Expense 0 0 0 0
Net Income -15,429,000 -15,085,000 -96,552,000 -7,586,000
Per Share
EPS -0.13 -0.12 -1.01 -0.11
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 18,720,000 31,249,000 29,752,000
Cost of Revenue 2,792,000 18,081,000 11,960,000
Gross Profit 15,928,000 13,168,000 17,792,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 22,203,000 31,098,000 25,133,000
Operating Expenses 157,860,000 110,525,000 102,946,000
Operating Income -141,932,000 -97,357,000 -85,154,000
Interest Expense 0 0 0
Income Before Tax -132,065,000 -88,848,000 -86,908,000
Income Tax Expense 0 -367,000 0
Net Income -132,065,000 -88,481,000 -86,908,000
Per Share
EPS -1.71 -1.27 -1.33
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 24,570,000 39,878,000 45,277,000
Short Term Investments 89,024,000 79,228,000 172,294,000
Net Receivables 318,000 298,000 484,000
Inventory 0 0 0
Total Current Assets 125,951,000 128,856,000 231,550,000
Property Plant Equipment 1,008,000 1,620,000 3,779,000
Goodwill and Intangibles 0 269,000 6,973,000
Total Assets 220,327,000 197,405,000 257,958,000
Liabilities
Account Payables 4,690,000 8,878,000 10,351,000
Short Term Debt 962,000 426,000 684,000
Total Current Liabilities 31,596,000 30,952,000 21,938,000
Long Term Debt 2,117,000 0 0
Total Liabilities 64,773,000 40,226,000 60,337,000
Shareholders Equity
Retained Earnings -902,861,000 -770,796,000 -682,315,000
Total Shareholders Equity 155,554,000 157,179,000 197,621,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 24,570,000 39,878,000 45,277,000
Short Term Investments 89,024,000 79,228,000 172,294,000
Net Receivables 318,000 298,000 484,000
Inventory 0 0 0
Total Current Assets 125,951,000 128,856,000 231,550,000
Property Plant Equipment 1,008,000 1,620,000 3,779,000
Goodwill and Intangibles 0 269,000 6,973,000
Total Assets 220,327,000 197,405,000 257,958,000
Liabilities
Account Payables 4,690,000 8,878,000 10,351,000
Short Term Debt 962,000 426,000 684,000
Total Current Liabilities 31,596,000 30,952,000 21,938,000
Long Term Debt 2,117,000 0 0
Total Liabilities 64,773,000 40,226,000 60,337,000
Shareholders Equity
Retained Earnings -902,861,000 -770,796,000 -682,315,000
Total Shareholders Equity 155,554,000 157,179,000 197,621,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -132,065,000 -88,481,000 -86,908,000
Depreciation & Amortization 807,000 863,000 797,000
Stock Based Compensation 10,856,000 20,542,000 15,039,000
Change in Working Capital 10,922,000 9,389,000 -1,195,000
Operating Cash Flow -20,075,000 -78,325,000 -67,567,000
Investing Activities
Capital Expenditure -121,000 -1,309,000 -605,000
Investments -121,000 -1,309,000 -605,000
Investing Cash Flow -69,769,000 46,220,000 12,628,000
Financing Activities
Debt Repayment 0 0 0
Common Stock Issued/Repurchased 74,913,000 26,714,000 72,867,000
Dividends Paid 0 0 0
Financing Cash Flow 74,536,000 26,706,000 72,867,000
Summary
Free Cash Flow -20,196,000 -79,634,000 -68,172,000
Net Change in Cash -15,308,000 -5,399,000 17,928,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -132,065,000 -88,481,000 -86,908,000
Depreciation & Amortization 807,000 863,000 797,000
Stock Based Compensation 10,856,000 20,542,000 15,039,000
Change in Working Capital 10,922,000 9,389,000 -1,195,000
Operating Cash Flow -20,075,000 -78,325,000 -67,567,000
Investing Activities
Capital Expenditure -121,000 -1,309,000 -605,000
Investments -121,000 -1,309,000 -605,000
Investing Cash Flow -69,769,000 46,220,000 12,628,000
Financing Activities
Debt Repayment 0 0 0
Common Stock Issued/Repurchased 74,913,000 26,714,000 72,867,000
Dividends Paid 0 0 0
Financing Cash Flow 74,536,000 26,706,000 72,867,000
Summary
Free Cash Flow -20,196,000 -79,634,000 -68,172,000
Net Change in Cash -15,308,000 -5,399,000 17,928,000